Coley amends IPO

Cancer, inflammation and infectious disease company Coley (Wellesley, Mass.) amended its IPO and now hopes to sell 6 million shares at $14-$16. A $15 deal price would raise $90 million and value the company at $372.6 million. The company originally filed to raise up to $115 million in April. Underwriters are Merrill Lynch; JPMorgan; Lazard; and Leerink Swann. ...